Renal Cell Carcinoma is More Aggressive in Turkish Patients with the Metabolic Syndrome |
Ozbek, Emin
(Department of Urology, Okmeydani Training and Research Hospital)
Otunctemur, Alper (Department of Urology, Okmeydani Training and Research Hospital) Sahin, Suleyman (Department of Urology, Okmeydani Training and Research Hospital) Dursun, Murat (Department of Urology, Okmeydani Training and Research Hospital) Besiroglu, Huseyin (Department of Urology, Okmeydani Training and Research Hospital) Koklu, Ismail (Department of Urology, Okmeydani Training and Research Hospital) Polat, Emre Can (Department of Urology, Balikligol State Hospital) Erkoc, Mustafa (Department of Urology, Okmeydani Training and Research Hospital) Danis, Eyyup (Department of Urology, Okmeydani Training and Research Hospital) Bozkurt, Muammer (Department of Urology, Okmeydani Training and Research Hospital) |
1 | Bruce WR, Giacca A, Medline A (2000). Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 9, 1271-9. |
2 | Bergstrom A, Hsieh CC, Lindblad P, et al (2001). Obesity and renal cell cancer a quantitative review. Br J Cancer, 85, 984. DOI ScienceOn |
3 | Bowers K, Albanes D, Limburg P, et al (2006). A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol, 164, 652-64. DOI ScienceOn |
4 | Chow W, Devesa S, Warren J, Fraumeni J Jr (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31. DOI ScienceOn |
5 | Pflug BR, Hong Z, Udan MS, et al (2007). Endothelin-1 promotes cell-survival in renal cell carcinoma through the ET[A] receptor. Cancer, 246, 139-48. |
6 | Rodriguez C, Patel AV, Mondul AM, et al (2005). Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol, 161, 147-52. DOI ScienceOn |
7 | Rini BI, Campbell SC, Escudier B (2009). Renal cell carcinoma. The Lancet, 373, 1119-32. DOI ScienceOn |
8 | Shanks JH (1999). Pathology of renal cell carcinoma: recent developments. Clin Oncol (R Coll Radiol), 11, 263-8. DOI ScienceOn |
9 | Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2002). A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control, 13, 417-26. DOI ScienceOn |
10 | Tall AR (1998). An overview of reverse cholesterol transport. Eur Heart J, 31-5. |
11 | Takahashi K, Totsune K, Murakami O (2001). Expression of three vasoactive peptides, urotensin- II, adrenomedullin, and endothelin-1, in a human renal cell carcinoma cell line, VMRC-RCW. Clin Exp Nephrol, 5, 246-9. DOI |
12 | Ulmer H, Borena W, Rapp K, et al (2009). Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer, 101, 1202-6. DOI ScienceOn |
13 | Weikert S, Ljungberg B (2010). Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol, 28, 247-52. DOI ScienceOn |
14 | Eichholzer M, Stahelin HB, Gutzwiller F, Ludin E, Bernasconi F (2000). Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr, 71, 569-74. DOI |
15 | Chow W, Gridley G, Fraumeni J, Jarvholm B (2000). Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med, 343, 1305-11. DOI ScienceOn |
16 | Chow WH, Dong LM, Devesa SS (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol, 7, 245-57. DOI ScienceOn |
17 | Choi JB, Yoon BI, Kim SJ, et al (2011). Changes in clinicopathological characteristics of renal cell carcinoma in the past 25 years: a single-center experience. Korean J Urol, 52, 110-4. DOI ScienceOn |
18 | Eckel RH (2007). Treating dyslipidemia of the metabolic syndrome: where's the evidence? Nat Clin Pract Endocrinol Metab, 3, 437. DOI ScienceOn |
19 | Fiorenza AM, Branchi A, Sommariva D (2000). Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res, 30, 141-5. DOI |
20 | Flaherty KT, Fuchs CS, Colditz GA, et al (2005). A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control, 16, 1099-106. DOI ScienceOn |
21 | Giovannucci E (2001). Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 131, 3109-20. DOI |
22 | Gorbachinsky I, Akpinar H, Assimos DG (2010). Metabolic syndrome and urologic diseases. Rev Urol, 12, 157-80. |
23 | Huang PL (2009). A comprehensive definition for metabolic syndrome. Dis Model Mech, 2, 231-7. DOI ScienceOn |
24 | Lindblad P, Chow WH, Chan J, et al (1999). The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia, 42, 107-12. DOI |
25 | Habib SL, Prihoda TJ, Luna M, Werner SA (2012). Diabetes and risk of renal cell carcinoma. J Cancer, 3, 42-8. DOI ScienceOn |
26 | Ibrahim MM (2010). Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev, 11, 11. DOI ScienceOn |
27 | Joh HK, Willett WC, Cho E (2011). Type 2 diabetes and the risk of renal cell cancer in women. Diabetes care, 34, 1552-6. DOI ScienceOn |
28 | Lowrance WT, Thompson RH, Yee DS, et al (2009). Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU International, 105, 16-20. |
29 | McLaughlin JK, Chow WH, Mandel JS, et al (1995). International renal-cell cancer study VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer, 63, 216-21. DOI ScienceOn |
30 | Pantuck AJ, Zisman A, Belldegrun AS (2001). The changing natural history of renal cell carcinoma. J Urol, 166, 1611-23. DOI ScienceOn |
31 | Patard JJ, Tazi H, Bensalah K, et al (2004). The changing evolution of renal tumours: a single center experience over a two-decade period. Eur Urol, 45, 490-3. DOI ScienceOn |
32 | Parker AS, Lohse CM, Cheville JC, et al (2006). Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urol, 68, 741. DOI ScienceOn |
![]() |